Pacific Bio (PACB) Tops Q3 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $55.69 million versus the consensus estimate of $48.72 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
• BeyondSpring Inc. (BYSI) Reports Q2 Loss of $0.02